Cambridge Investment Research Advisors’s Affirm AFRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$808K Buy
9,913
+870
+10% +$56.9K ﹤0.01% 2502
2026
Q1
$414K Sell
9,043
-2,278
-20% -$132K ﹤0.01% 2980
2025
Q4
$843K Buy
11,321
+2,879
+34% +$207K ﹤0.01% 2237
2025
Q3
$617K Buy
8,442
+2,316
+38% +$176K ﹤0.01% 2472
2025
Q2
$424K Buy
+6,126
New +$318K ﹤0.01% 2687
2025
Q1
Sell
-10,627
Closed -$647K 3501
2024
Q4
$647K Buy
+10,627
New +$591K ﹤0.01% 2219
2024
Q1
Sell
-5,017
Closed -$247K 3304
2023
Q4
$247K Buy
+5,017
New +$145K ﹤0.01% 2749
2022
Q2
Sell
-8,309
Closed -$385K 3046
2022
Q1
$385K Sell
8,309
-31,420
-79% -$1.64M ﹤0.01% 2329
2021
Q4
$4M Buy
39,729
+18,989
+92% +$2.51M 0.02% 757
2021
Q3
$2.47M Buy
+20,740
New +$1.66M 0.01% 981

Other funds holding AFRM

Cambridge Investment Research Advisors's AFRM Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Affirm (AFRM) stake by 9.6% in Q2 2026, buying an estimated $56.9K and bringing the position to 9,913 shares worth $808K. The position accounts for ﹤0.01% of the portfolio, ranked #2502.

Cambridge Investment Research Advisors first reported a position in AFRM in Q3 2021 and has held it in 10 quarters since. The position peaked at $4M in Q4 2021. 656 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • Cambridge Investment Research Advisors held 9,913 shares of Affirm worth $808K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 870 Affirm shares in Q2 2026, an estimated $56.9K.
  • Affirm made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2502 holding.
  • Cambridge Investment Research Advisors first reported a position in Affirm in Q3 2021 and has held it in 10 quarters since.
  • Cambridge Investment Research Advisors's Affirm position peaked at $4M in Q4 2021.
  • 656 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.